Navigation Links
Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial
Date:3/25/2009

ung and ovarian cancers that are refractory (have not responded) to standard therapy or for which no curative standard therapy exists.

The primary objective of the trial was to determine the Maximum Tolerated Dose (MTD), Dose-Limiting Toxicity (DLT), recommended dose and dosing schedule and safety profile of REOLYSIN when administered in combination with gemcitabine. Secondary objectives include the evaluation of immune response to the drug combination, the body's response to the drug combination compared to chemotherapy alone and any evidence of anti-tumour activity.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN, its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit www.oncolyticsbiotech.com

Gemzar(R) is indicated for NSCLC, breast, pancreatic and ovarian cancer. For more information about Gemzar(R), please visit www.gemzar.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the U.K. and U.S. combination REOLYSIN/gemcitabine clinical trials and the Company's belief as to the potential of REOLYSIN as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue researc
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech(R) Inc. Collaborators Present Reovirus Research at Replicating Oncolytic Virus Meeting
2. Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial
3. Oncolytics Biotech(R) Inc. Collaborators Update Combination REOLYSIN(R) and Docetaxel Trial Results at Replicating Oncolytic Virus Meeting
4. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting
5. Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
6. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America
7. Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent
8. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
9. Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference
10. Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data
11. Oncolytics Biotech Inc. Announces U.S. Phase II Sarcoma Clinical Trial Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... Until recently, pets suffering from arthritic ailments had ... pain. Pill therapies are costly, can be harmful to ... , The procedure uses adult (not embryonic) animal stem ... healing power. MediVet's equipment enable veterinarians to remove a ... cells, then activate and inject the cells into the ...
(Date:9/11/2014)... 11, 2014 Europe ... of its biocompatible, non-toxic and non-leaching antimicrobial Sanipolymers™. Parx ... one of the top tech startups of ... to create antimicrobial plastics. Consumers are becoming ... surfaces use hazardous substances. These substances or additives can ...
(Date:9/11/2014)... Follow us on LinkedIn ... launch of a major research program analysing the ... to participate in this comprehensive grassroots level global ... technologists and market strategists. The new report to ... global market developments including major technologies, trends and ...
(Date:9/11/2014)... 2014 The Remedy Group , ... managed care organizations, has announced that Terry Souwannamuang has ... his years in biopharma and managed care Terry steadily ... starting a brand new specialty pharmacy for a Portland-based ... is unparalleled. Terry has a Bachelor’s Degree in General ...
Breaking Biology Technology:MediVet America Secures Exclusive Worldwide License with Nanofiber Veterinary 2World's First Biocompatible and Non-toxic Antibacterial Plastic 2Growing Per Capita Meat Consumption Drives Growth in the Global Feed Acidifiers Market, According to an Upcoming Report by Global Industry Analysts, Inc. 2Growing Per Capita Meat Consumption Drives Growth in the Global Feed Acidifiers Market, According to an Upcoming Report by Global Industry Analysts, Inc. 3The Remedy Group Announces Hiring of Managed Care and Specialty Pharmacy Veteran 2
... 22 GeneGo, Inc., a leading provider of software ... , today announced that the University of Cardiff has ... researchers will have access to GeneGo,s MetaCore, training and ... their partner relationship with GeneGo to provide a pathway ...
... firm, SiliconSky GPS, designs and develops a GPS-enabled asthma inhaler that ... triggers. , ... Red Lodge, MT (PRWEB) April 22, ... and product design firm, announced today that is has successfully completed ...
... Manufacturers of America (PhRMA) and the national consumer health ... three key policies designed to help achieve high-quality, affordable ... will work together and will reach out to other ... the healthcare reform proposals to be considered this year. ...
Cached Biology Technology:Cardiff University Becomes a GeneGo Center of Excellence 2SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program 2SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program 3PhRMA, Families USA Jointly Promote Measures to Ensure Quality, Affordable Healthcare Coverage 2PhRMA, Families USA Jointly Promote Measures to Ensure Quality, Affordable Healthcare Coverage 3
(Date:9/12/2014)... September 12, 2014 ... the addition of the  "Global Facial Recognition ... and Facial Analytics) - Industry Analysis, Size, ... 2020"  report to their offering. ... facial recognition market was valued at USD ...
(Date:9/12/2014)... by City College of New York biologist Mike Hickerson, a ... that explains how so many species of birds ended up ... from Mexico to the southernmost tip of South America. It ... "The unanswered question has beenhow did this extraordinary bird diversity ... on the subject published in the journal Nature ...
(Date:9/12/2014)... displacing data storage and processing from the user,s computer ... more storage space and computing power that they can ... having to connect to a single desktop or other ... raised concerns about the increased energy demands of sustaining ... where an individual user,s laptop might be shut down ...
Breaking Biology News(10 mins):Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 2Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 3Cutting the cloud computing carbon cost 2
... Annual Meeting & OTO EXPO of the American Academy of ... meeting of ear, nose, and throat doctors in the world, ... Featuring more than 305 scientific research sessions, 594 posters, and ... is a unique opportunity for journalists from around the world ...
... by a North Carolina State University researcher has shown ... act like solar cells to produce electricity. The findings ... closely mimic nature. They also have the potential to ... current standard-bearer: silicon-based solar cells. The bendable devices ...
... study has determined that teenagers who have abortions are no ... their peers whose pregnancies do not end in abortion. ... University of California, San Francisco, is the first to use ... representative sample of adolescents. The researchers found that young ...
Cached Biology News:2010 AAO-HNSF miniseminars: Sunday, Sept. 26, 2010 22010 AAO-HNSF miniseminars: Sunday, Sept. 26, 2010 3Mimicking nature, water-based 'artificial leaf' produces electricity 2National study: Abortion does not cause depression or low self-esteem in adolescents 2National study: Abortion does not cause depression or low self-esteem in adolescents 3
... 'Agilents GeneSpring Workgroup solution is ... managing and mining expression data in ... and is deployed in over 40 ... research organizations worldwide. GeneSpring Workgroup streamlines ...
... Best: DASGIPs Process Control integrates Process ... comprehensive documentation for cultivation processes. A ... pH, dissolved oxygen, temperature and agitation ... Profiles, e.g. constant or scheduled media ...
... a genome-wide microRNA (miRNA) expression profiling service ... which enable highly sensitive and specific direct ... arrays for mature miRNA of all species ... Sanger miRBase database (Release 8.2). Our service ...
... PEP-165 is an 18 amino acid synthetic peptide whose sequences are ... is (amino to carboxy terminus): S(21) - S - M - ... - E - A - I - D - K - ... This peptide may be used for neutralization and control ...
Biology Products: